GE HealthCare Technologies Inc. with ticker code (GEHC) have now 12 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $97.00 and $66.00 and has a mean share price target at $83.88. (at the time of writing). Given that the stocks previous close was at $73.91 this now indicates there is a potential upside of 13.5%. The 50 day moving average now sits at $73.72 while the 200 day moving average is $73.82. The market capitalization for the company is 33.42B. The stock price for the company is currently $73.41 USD
The potential market cap would be $37,927,459,276 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 21.78, revenue per share of $42.36 and a 6.17% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
